NEW YORK (GenomeWeb) – RainDance Technologies has appointed Martin Coyne II and Glenn Muir to its board of directors.

Coyne retired from Eastman Kodak in July 2003. He had served there as president of health imaging, president of the commercial business group, and most recently as executive VP of Eastman Kodak and group executive of the photography group. He is chairman of the board of RockTech, a privately held SaaS business, and sits on the board of Akamai.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.